Mallinckrodt reaches $1.6B opioid settlement calling for generics unit bankruptcy
February 25, 2020 at 08:23 AM EST
Mallinckrodt PLC said Tuesday it has reached a $1.6 billion agreement to settle opioid-related claims against the company that would call for Chapter 11 bankruptcy filing by certain specialty-generics subsidiaries. The company also reached a debt refinancing agreement.
